ADARTREL

Brand name authorized in: Germany Spain France Netherlands Poland United Kingdom

Active ingredients

The drug ADARTREL contains one active pharmaceutical ingredient (API):

1 Ropinirole
UNII D7ZD41RZI9 - ROPINIROLE HYDROCHLORIDE

Ropinirole is a non-ergoline D2/D3 dopamine agonist which stimulates striatal dopamine receptors. Ropinirole alleviates the dopamine deficiency which characterises Parkinson’s disease by stimulating striatal dopamine receptors.

Read about Ropinirole

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Ropinirole
N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists
Discover more medicines within N04BC04

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
Summary of product characteristics (SPC)
UK

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
DE
Bundesinstitut für Arzneimittel und Medizinprodukte
Identifier(s): 00070147, 01604869, 02952785, 02952940, 04173329, 04173341, 04173358
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 67919, 67921, 67922
FR
Base de données publique des médicaments
Identifier(s): 67276995, 69422057, 69982928
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 104209, 104216, 104223, 140439, 140501, 140507, 161354, 161356, 161358, 185446, 185448
NL
Z-Index G-Standaard, PRK
Identifier(s): 80519, 80527, 80535
PL
Rejestru Produktów Leczniczych
Identifier(s): 100163756, 100163762, 100163800